Aclarion (NASDAQ:ACON – Get Free Report) posted its earnings results on Wednesday. The company reported ($1.34) EPS for the quarter, topping analysts’ consensus estimates of ($1.55) by $0.21, Zacks reports. Aclarion had a negative return on equity of 52.31% and a negative net margin of 9,517.11%.
Aclarion Price Performance
NASDAQ ACON opened at $3.28 on Thursday. The business’s fifty day moving average price is $3.29 and its 200-day moving average price is $4.46. The stock has a market capitalization of $8.07 million, a price-to-earnings ratio of -0.19 and a beta of 1.18. Aclarion has a 1-year low of $2.34 and a 1-year high of $12.03.
Analyst Ratings Changes
A number of analysts have commented on the company. Weiss Ratings lowered Aclarion from a “sell (e+)” rating to a “sell (e)” rating in a report on Friday, May 8th. Wall Street Zen raised Aclarion from a “sell” rating to a “hold” rating in a report on Saturday, March 28th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Aclarion currently has a consensus rating of “Sell”.
Aclarion declared that its board has authorized a stock repurchase plan on Wednesday, April 22nd that permits the company to buyback $2.50 million in outstanding shares. This buyback authorization permits the company to purchase up to 31% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.
About Aclarion
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.
Read More
- Five stocks we like better than Aclarion
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
